Advertisement

PharmacoEconomics & Outcomes News

, Volume 834, Issue 1, pp 37–37 | Cite as

Olaparib for first-line maintenance in advanced ovarian cancer

Media release
  • 4 Downloads

Reference

  1. NICE. Innovative treatment for gynaecological cancers approved for Cancer Drugs Fund. Internet Document : 26 Jul 2019. Available from: URL: https://www.nice.org.uk/news/article/innovative-treatment-for-gynaecological-cancers-approved-for-cancer-drugs-fund

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations